Charles G. Raver assists clients across of a range of topics from drug and device development to litigation and enforcement matters in FDA-regulated industries. Mr. Raver joined Hyman, Phelps & McNamara after spending more than a decade in biomedical research studying the neurobiological mechanisms of chronic pain and sensory processing. He now leverages his deep knowledge of neuroscience, laboratory management, pre-clinical animal research, and study design to help clients understand the regulatory landscape faced by the life sciences industry.
Mr. Raver graduated with honors from the University of Maryland Carey School of Law. While in law school, Mr. Raver served as a staff editor and the first social media chair for the Journal of Health Care Law & Policy. He also received two CALI awards after nabbing the top grade in courses on Animal Law and Written and Oral Advocacy. Throughout law school, Mr. Raver continued his neurobiology research career full-time. His research resulted in seven peer-reviewed publications, which have identified potential therapeutic targets for treating chronic pain and demonstrated the functions of neural circuits responsible for sensory processing. Mr. Raver also has extensive knowledge and direct experience with advanced techniques driving development of many current biomedical therapies, such as optogenetics, chemogenetics, viral vector-mediated transgene delivery, and targeted neural stimulation techniques.